Risk score for non-small cell lung cancer patients starting checkpoint inhibitor treatment.
Diem S, Fässler M, Hasan Ali O, Siano M, Niederer R, Berner F, Roux GA, Ackermann CJ, Schmid S, Güsewell S, Früh M, Flatz L.
Diem S, et al. Among authors: flatz l.
Cancer Manag Res. 2018 Nov 8;10:5537-5544. doi: 10.2147/CMAR.S179767. eCollection 2018.
Cancer Manag Res. 2018.
PMID: 30519101
Free PMC article.